Medacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium

10-Nov-2017 Intellasia | BusinessWire | 6:00 AM Print This Post

- More than 300 medical professionals in attendance, with
presentations from over 40 international surgeons

- Scientific sessions available for viewing on Medacta’s website

FUKUOKA, Japan–(BUSINESS WIRE)–Medacta Japan, a subsidiary of Medacta International, the privately
held, family-owned global leader in the design of innovative joint
replacement and spine surgery products, today announced the success of
its 2nd Japanese M.O.R.E Symposium, held on September 30 to
October 1, 2017 and attended by over 300 medical professionals.

Reflecting Medacta’s ongoing commitment to continuous medical education,
the event focused on how implant design, techniques and patient-specific
treatment can improve outcomes and patient satisfaction in the changing
orthopaedic landscape, positively impacting the sustainability of the
healthcare system.

More than 40 Japanese orthopaedic surgery experts presented at the
meeting, covering topics on innovation, education and healthcare
sustainability, with important contributions from international experts
who traveled from Australia, Europe and the United States to attend the

“Surgical education and training has been a pillar of Medacta’s mission
and identity since the company began. We believe it is the foundation
for optimal clinical outcomes and both patient and surgeon
satisfaction,” said Francesco Siccardi, Executive Vice President of
Medacta International. “The success and the incredible growth of Medacta
Japan, in both joint and spine, is a further confirmation of that
belief. We’re honored that a growing number of surgeons depend on us as
a reliable partner, and we will do our best to maintain our vision for a
bright future in Japan.”

For more information about the 2nd Japanese M.O.R.E.
Symposium and Medacta, including scientific sessions, visit:

About Medacta International

Medacta® International is a world leading manufacturer of
orthopedic implants, neurosurgical systems, and instrumentation.
Medacta’s revolutionary approach and responsible innovation have
resulted in standard of care breakthroughs in hip replacement with the
AMIS® system and total knee replacement with MyKnee®
patient matched technology. Over the last 10 years, Medacta has grown
dramatically by taking a different approach and placing value on all
aspects of the care experience from design to training to
sustainability. Medacta is headquartered in Castel San Pietro,
Switzerland, and operates in over 30 countries. To learn more about
Medacta International, please visit
or follow @Medacta on Twitter.


For Medacta International, Inc.
Jill Bongiorni, 516-729-2250
[email protected]


Category: BusinessWire, PRAsia

Print This Post

Comments are closed.